EUVIMEDEUVIMED entdecken
Crossref

Flow cytometric analysis of CD34 + CD38 − cells; cell frequency and immunophenotype based on CD45RA expression pattern

Shumpei Mizuta iD, Makoto Iwasaki, Noriko Bandai, Saya Yoshida, Asami Watanabe, Hiroshi Takashima, Takeshi Ueshimo, Kazuhiro Bandai, Kensuke Fujiwara, Naoko Hiranuma, Yusuke Koba, Takahito Kawata und 2 weitere

Cytometry Part B: Clinical Cytometry · 2024

DOI: 10.1002/cyto.b.22148 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cytometry Part B: Clinical Cytometry, 2024. Verfasst von Shumpei Mizuta und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Hyogo Prefectural Amagasaki General Medical Center, Amagasaki, Hyogo, Japan. Hauptthemen laut MEDLINE: Hematopoietic Stem Cells, Leukemia, Myeloid, Acute. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 21 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science (JSPS).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The CD34 + CD38 − population in bone marrow includes hematopoietic stem/progenitor cells. Recently, in acute myeloid leukemia, the focus has shifted to flow cytometry analysis targeting CD34 + CD38 − leukemic cells due to their effectiveness in minimal/measurable residual disease detection and prognosis prediction. Nevertheless, the immunophenotype and cell frequency of these cells in the bone marrow, in the absence of leukemic cells, remains unknown. We aimed to evaluate detailed characteristics of CD34 + CD38 − cells in both normal and leukemic cells by flow cytometry.

Methods

We compared the cell frequency and immunophenotype of the CD34 + CD38 − fraction in the following groups: patients with idiopathic thrombocytopenic purpura and malignant lymphoma as controls ( n = 17), post‐treatment patients without abnormal blasts ( n = 35), and patients with myeloid malignancies ( n = 86). The comparison was based on the presence or absence of CD45RA expression, a marker commonly used to prospectively isolate lymphoid‐primed cell populations within the CD34 + CD38 − fraction.

Results

The CD34 + CD38 − CD45RA + cell population exhibited a significant expansion in bone marrow without leukemic cells 1 month after cord blood transplantation and in various type of myeloid malignancies, compared to the control group ( p < 0.01). Continuous CD45RA expression and notable expansion of the CD34 + CD38 − CD45RA − population were exclusively observed in myelodysplastic syndrome‐related diseases. The CD34 + CD38 − CD45RA + population displayed frequent expression of various markers in both leukemic and non‐leukemic cells, in contrast to the CD34 + CD38 − CD45RA − population.

Conclusions

The CD34 + CD38 − fraction should be carefully evaluated considering the nature of normal hematopoietic precursor cells, their cell frequency and immunophenotype, including CD45RA expression pattern, for improving the accuracy of myeloid malignancy diagnosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematopoietic Stem CellsLeukemia, Myeloid, AcuteHumansADP-ribosyl Cyclase 1Flow CytometryAntigens, CD34Leukocyte Common AntigensCell Adhesion MoleculesNeoplastic Stem CellsNeoplasm, Residual

Stichwörter der Autor:innen

CD34+CD38−acute myeloid leukemiaflow cytometryhematopoietic stem/progenitor cellleukemic stem cell

Substanzen

ADP-ribosyl Cyclase 1Antigens, CD34Leukocyte Common AntigensCell Adhesion Molecules

Autor:innen und Institutionen

  • Department of Clinical Laboratory, Hyogo Prefectural Amagasaki General Medical Center, Amagasaki, Hyogo, Japan.
  • Laboratory of Hematology, Division of Medical Biophysics, Kobe University Graduate School of Health Sciences, Kobe, Hyogo, Japan.
  • Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Department of Clinical Laboratory, Hyogo Prefectural Nishinomiya Hospital, Nishinomiya, Hyogo, Japan.
  • Department of Hematology, Hyogo Prefectural Amagasaki General Medical Center, Amagasaki, Hyogo, Japan.

ORCID-Profile: Shumpei Mizuta

Förderung

  • Japan Society for the Promotion of Science (JSPS)

Zitieren

APA

Mizuta, S., Iwasaki, M., Bandai, N., Yoshida, S., Watanabe, A., Takashima, H., Ueshimo, T., Bandai, K., Fujiwara, K., Hiranuma, N., Koba, Y., Kawata, T., Tamekane, A., & Watanabe, M. (2024). Flow cytometric analysis of CD34 + CD38 − cells; cell frequency and immunophenotype based on CD45RA expression pattern. Cytometry Part B: Clinical Cytometry. https://doi.org/10.1002/cyto.b.22148

Vancouver

Mizuta S, Iwasaki M, Bandai N, Yoshida S, Watanabe A, Takashima H, et al. Flow cytometric analysis of CD34 + CD38 − cells; cell frequency and immunophenotype based on CD45RA expression pattern. Cytometry Part B: Clinical Cytometry. 2024. doi:10.1002/cyto.b.22148

BibTeX
@article{Mizuta2024,
  author = {Mizuta, Shumpei and Iwasaki, Makoto and Bandai, Noriko and Yoshida, Saya and Watanabe, Asami and Takashima, Hiroshi and Ueshimo, Takeshi and Bandai, Kazuhiro and Fujiwara, Kensuke and Hiranuma, Naoko and Koba, Yusuke and Kawata, Takahito and Tamekane, Akira and Watanabe, Mitsumasa},
  title = {Flow cytometric analysis of CD34 + CD38 − cells; cell frequency and immunophenotype based on CD45RA expression pattern},
  journal = {Cytometry Part B: Clinical Cytometry},
  year = {2024},
  doi = {10.1002/cyto.b.22148}
}
Kostenlos starten →